INSERM, Lille, France 
Alzheimer, Parkinson
"Marie-Christine CHARTIER-HARLIN"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Drouyer M, Bolliger MF, Lobbestael E, et al. (2021) Protein phosphatase 2A holoenzymes regulate leucine-rich repeat kinase 2 phosphorylation and accumulation. Neurobiology of Disease. 105426
Goveas L, Mutez E, Chartier-Harlin MC, et al. (2021) Mind the Gap: LRRK2 Phenotypes in the Clinic vs. in Patient Cells. Cells. 10
Desplanque M, Bonte MA, Gressier B, et al. (2020) Trends in Glucocerebrosides Research: A Systematic Review. Frontiers in Physiology. 11: 558090
Belarbi K, Cuvelier E, Bonte MA, et al. (2020) Glycosphingolipids and neuroinflammation in Parkinson's disease. Molecular Neurodegeneration. 15: 59
Rideout HJ, Chartier-Harlin MC, Fell MJ, et al. (2020) The Current State-of-the Art of LRRK2-Based Biomarker Assay Development in Parkinson's Disease. Frontiers in Neuroscience. 14: 865
Marchand A, Drouyer M, Sarchione A, et al. (2020) LRRK2 Phosphorylation, More Than an Epiphenomenon. Frontiers in Neuroscience. 14: 527
Keo A, Mahfouz A, Ingrassia AMT, et al. (2020) Transcriptomic signatures of brain regional vulnerability to Parkinson's disease. Communications Biology. 3: 101
Fernández B, Lara Ordóñez AJ, Fdez E, et al. (2019) Centrosomal cohesion deficits as cellular biomarker in lymphoblastoid cell lines from LRRK2 Parkinson's disease patients. The Biochemical Journal
Cuvelier E, Méquinion M, Leghay C, et al. (2018) Overexpression of Wild-Type Human Alpha-Synuclein Causes Metabolism Abnormalities in Thy1-aSYN Transgenic Mice. Frontiers in Molecular Neuroscience. 11: 321
Taymans JM, Chartier-Harlin MC. (2018) In silico and Wet Bench Interactomics Sheds Light on the Similitudes and Differences between Human ROCO Proteins. Proteomics. e1800103
See more...